Karen Chapman

2015

In 2015, Karen Chapman earned a total compensation of $395.8K as VP of Research at Oncocyte Corp, a 118% increase compared to previous year.

Compensation breakdown

Bonus$55,000
Option Awards$145,424
Salary$186,732
Other$8,642
Total$395,798

Chapman received $186.7K in salary, accounting for 47% of the total pay in 2015.

Chapman also received $55K in bonus, $145.4K in option awards and $8.6K in other compensation.

Rankings

In 2015, Karen Chapman's compensation ranked 11,597th out of 13,638 executives tracked by ExecPay. In other words, Chapman earned more than 15.0% of executives.

ClassificationRankingPercentile
All
11,597
out of 13,638
15th
Division
Manufacturing
4,446
out of 5,187
14th
Major group
Chemicals And Allied Products
1,640
out of 1,857
12th
Industry group
Drugs
1,356
out of 1,531
11th
Industry
In Vitro and In Vivo Diagnostic Substances
64
out of 76
16th
Source: SEC filing on April 29, 2016.

Chapman's colleagues

We found six more compensation records of executives who worked with Karen Chapman at Oncocyte Corp in 2015.

2015

William Annett

Oncocyte Corp

Chief Executive Officer

2015

Alfred Kingsley

Oncocyte Corp

Chairman

2015

Kristine Mechem

Oncocyte Corp

VP of Marketing

2015

Robert Peabody

Oncocyte Corp

Chief Financial Officer

2015

Joseph Wagner

Oncocyte Corp

Chief Executive Officer

2015

Lyndal Hesterberg

Oncocyte Corp

Senior VP of Research and Development

You may also like